The company achieved positive EBITDA of $2.7 million versus adjusted EBITDA of $504,851 in the second quarter of 2018.
It also reported gross profits before biological adjustments of $9.7 million or 58.7%, higher by 333% from the second quarter of 2018, when the figure was $2.2 million, or 50.8%.
Planet 13's second-quarter net income before taxes was $1.1 million, compared to a net loss of $6.1 million in the second quarter of 2018.
Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.
"Q2 was another great quarter for Planet 13 as SuperStore sales grew 19.4% sequentially over Q1," co-CEO Larry Scheffler said in a statement.
“We are growing sales on both an absolute basis and as a percentage of the total market. Our Phase II expansion is progressing at full speed, with the goal of opening at the end of the third quarter. Phase II, which includes a 15,000-square-foot, customer-facing production facility, a restaurant, a coffee shop, and event space, will build on Planet 13's leading position in Las Vegas by creating an experience no other dispensary can offer.”
Planet 13 shares were down 4.06% at $1.80 at the time of publication Friday.
Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter
See more from Benzinga
- Cansortium Attributes Lower Q2 Revenue To 'Unexpected Delays,' Halves 2019 Outlook
- True Leaf Brands Reports Q1 Financials, Says CBD Supplements For Dogs Hit Shelves In September
- Emerald Health Therapeutics Discloses Q2 Sales Of .1M
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.